TriSalus Life Sciences Inc Live Stock Price Today, Share Analysis and Chart

Name: TriSalus Life Sciences Inc: Is Infosys Ltd. worth buying?
Item: TriSalus Life Sciences Inc
Rating: 0.80250
Author: Trendlyne DVM scores

about

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two produ...

4.56 -0.09 (-1.94%)

33.33% Gain from 52W Low

53,755

XNAS Volume

XNAS 01 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

2.5 / 100

Technically Bearish

29.6 / 100

1Yr Price target upside is 149%

7 analysts

TriSalus Life Sciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

TriSalus Life Sciences Inc Live Stock Price Today, Share Analysis and Chart

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two produ...

33.33% Gain from 52W Low

SWOT Analysis

TriSalus Life Sciences Inc Live Price Chart